INTRODUCTION
Multimorbidity, the simultaneous coexistence in individuals of more than one disease state, has become increasingly common in health care settings (1, 2). Patients who have multimorbidity are more likely to be admitted to hospital, experience premature death or a loss of physical functioning and have poor quality of life (3).
Patients with significant multimorbidity are usually excluded from clinical trials. This has led to a scarcity of evidence in relation to appropriate interventions in this group (4). The lack of reporting of multimorbidity in patients enrolled in clinical trial in acute settings, limits the applicability of some research findings to the patient groups that has multimorbidity (5, 6).
Established cardiovascular disease, hypertension and diabetes are common and important diagnoses. These conditions often coexist and have increased prevalence with age. In patients with established cardiovascular disease, both hypertension and diabetes are associated with a significantly increased risk of cardiovascular mortality and morbidity (7-11).
The significance of improving the care of patients with multimorbidity alongside cardiovascular disease has been highlighted in earlier reports (10, 12).
However, there is little evidence regarding the magnitude of multimorbidity, their …show more content…
The current study used a cohort of patients admitted to medical intensive care unit with a diagnosis of cardiovascular disease. The study examined the magnitude of multimorbidity, whether a relationship exists between the level of multimorbidity and cardiovascular mortality and predictors of
Multimorbidity, the simultaneous coexistence in individuals of more than one disease state, has become increasingly common in health care settings (1, 2). Patients who have multimorbidity are more likely to be admitted to hospital, experience premature death or a loss of physical functioning and have poor quality of life (3).
Patients with significant multimorbidity are usually excluded from clinical trials. This has led to a scarcity of evidence in relation to appropriate interventions in this group (4). The lack of reporting of multimorbidity in patients enrolled in clinical trial in acute settings, limits the applicability of some research findings to the patient groups that has multimorbidity (5, 6).
Established cardiovascular disease, hypertension and diabetes are common and important diagnoses. These conditions often coexist and have increased prevalence with age. In patients with established cardiovascular disease, both hypertension and diabetes are associated with a significantly increased risk of cardiovascular mortality and morbidity (7-11).
The significance of improving the care of patients with multimorbidity alongside cardiovascular disease has been highlighted in earlier reports (10, 12).
However, there is little evidence regarding the magnitude of multimorbidity, their …show more content…
The current study used a cohort of patients admitted to medical intensive care unit with a diagnosis of cardiovascular disease. The study examined the magnitude of multimorbidity, whether a relationship exists between the level of multimorbidity and cardiovascular mortality and predictors of